• About us
• Contact

Advertisement

Document › Details

Medigene AG. (4/7/25). "Press Release: Medigene AG Files Application for the Opening of Insolvency Proceedings". Planegg.

	Region	München (Munich)
	Country	Germany
	Organisation	Medigene AG (FSE: MDG1, Prime Standard)
	Group	Medigene (Group)
	Organisation 2	Frankfurt Stock Exchange (FSE)
	Group	Deutsche Börse (Group)
	Product	BIOTECH
	Product 2	investment banking

The Executive Management Board supported by the Supervisory Board of Medigene AG (FWB: MDG1, Prime Standard) announces that the Company intends to file for the opening of insolvency proceedings with the competent local court in the near future.

This step was taken because the Company – in taking a conservative approach – now estimates itself to be overindebted as a result of reconsideration of the valuation of Company’s assets in light of its current economic situation and is expected to be illiquid in May 2025.


Emitter: Medigene AG
Lochhamer Straße 11
82152 Planegg/Martinsried
Germany
Contact Person: Medigene PR/IR
Phone: +49 89 2000 3333 01
E-Mail: [email protected]
Website: www.medigene.de
ISIN(s): DE000A40ESG2 (Share)
Stock Exchange(s): Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate

Record changed: 2025-04-10

Advertisement

More documents for Medigene (Group)

• [1] Medigene AG. (3/28/25). "Press Release: Notification of Loss of Half of the Share Capital According to § 92 AktG and Cash Runway Amendment". Planegg....
• [2] Medigene AG. (2/27/25). "Press Release: Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers". Planegg....
• [3] Medigene AG. (11/26/24). "Press Release: Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment". Basel....
• [4] Medigene AG. (9/5/24). "Press Release: Medigene Announces U.S. FDA Clearance of IND Application for MDG1015 for Multiple Solid Tumor Indications". Planegg....
• [5] Medigene AG. (8/8/24). "Press Release: Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers". Planegg-Martinsried....
• [6] Medigene AG. (11/21/23). "Press Release: Medigene AG Announces Prioritization of Pipeline and Resource Allocation as Well as Extension of Cash Runway". Planegg....
• [7] Medigene AG. (5/3/23). "Press Release: Medigene AG Reports Financial Results and Business Update for Q1 2023". Martinsried....
• [8] Medigene AG. (5/2/23). "Press Release: Medigene Acquires Worldwide, Exclusive License of CD40L-CD28 Costimulatory Switch Receptor". Planegg....
• [9] Medigene AG. (2/1/23). "Press Release: Medigene AG Appoints Pamela Keck as Vice President of Investor Relations and Corporate Communications". Planegg....
• [10] Medigene AG. (1/18/23). "Press Release: Medigene Receives $3 Million Milestone Payment from 2seventy bio". Planegg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.